Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT06671067
Eligibility Criteria:
Inclusion Criteria:
1. Patients were required to be aged ≥ 18 years and to be hospitalized for a primary diagnosis of AMI,
2. AMI patients accompanied by cardiac insufficiency following coronary revascularization, which is characterized by the symptoms and signs of fluid overload, regardless of left ventricular ejection fraction (LVEF), and have an N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration of ≥ 400 pg/L or a BNP concentration of ≥ 100 pg/L.
Exclusion Criteria:
1. Patient's physical characteristics that prevented the use of the ReDS system (height of \<155 or \>190 cm; body mass index of \<22 or \>39 kg/m2)
2. Patients with chronic obstructive pulmonary disease or other lung diseases that might confound ReDS values
3. Patients with a left ventricular assist device or undergoing cardiac transplantation;
4. Patients with congenital heart malformations or intrathoracic mass that would affect right lung anatomy;
5. Patients with end-stage renal disease on hemodialysis;
6. Patients whose life expectancy less than 12 months due to noncardiac comorbidities
7. Patients who participate in another randomized studies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06671067
Study Brief:
Protocol Section:
NCT06671067